Pricing Log in Create free account

Cerenome, Inc. (CNSY) vs Pasithea Therapeutics Corp. (KTTA)

Cerenome, Inc. and Pasithea Therapeutics Corp. are both Biotechnology companies. Cerenome, Inc. and Pasithea Therapeutics Corp. are of similar size ($14.3M and $13.7M). Pasithea Therapeutics Corp. has the higher net margin (0.00% vs −526.5%) and the higher return on invested capital (−367.5% vs −532.8%). Across the 15 metrics below, Pasithea Therapeutics Corp. leads on 10 and Cerenome, Inc. on 5.

Valuation

Metric CNSY KTTA Biotechnology median
P/E n/m n/m 8.50
P/S 2.79 27.71 9.71
P/B 2.15 0.27 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.39 0.64
EV/Sales 3.29 (66.34) 9.21
Earnings yield (197.65%) (376.19%) (33.15%)
Free cash flow yield (205.49%) (130.85%) (25.50%)

Profitability

Metric CNSY KTTA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (628.12%) 0.00% 0.00%
Net margin (526.48%) 0.00% 0.00%
Free cash flow margin (560.29%) 0.00% 0.00%
Return on equity (520.84%) (65.49%) (56.36%)
Return on assets (181.53%) (61.97%) (48.04%)
Return on invested capital (532.77%) (367.46%) 0.00%

Growth

Metric CNSY KTTA Biotechnology median
Revenue growth (TTM) (20.95%) — 6.02%
EPS growth (last fiscal year) 82.79% 77.07% 30.26%
Revenue growth, 5-year CAGR (5.72%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNSY KTTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.37 26.25 4.72
Net debt to EBITDA 0.83 2.74 0.96

Dividend

Metric CNSY KTTA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CNSY KTTA Biotechnology median
Market cap 14.27m 13.70m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack